323 related articles for article (PubMed ID: 31352632)
1. Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.
Choi JY; Kang HJ; Hong KT; Hong CR; Lee YJ; Park JD; Phi JH; Kim SK; Wang KC; Kim IH; Park SH; Choi YH; Cheon JE; Park KD; Shin HY
Int J Clin Oncol; 2019 Dec; 24(12):1515-1525. PubMed ID: 31352632
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults.
Lee SH; Son MH; Sung KW; Choi YB; Lee NH; Yoo KH; Koo HH; Lim DH; Shin HJ
J Neurooncol; 2014 Dec; 120(3):507-13. PubMed ID: 25108776
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of high-dose
Lee JW; Lee S; Cho HW; Ma Y; Yoo KH; Sung KW; Koo HH; Cho EJ; Lee SK; Lim DH
J Hematol Oncol; 2017 May; 10(1):108. PubMed ID: 28511709
[TBL] [Abstract][Full Text] [Related]
4. Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents.
Lee JW; Lim DH; Sung KW; Lee HJ; Yi ES; Yoo KH; Koo HH; Suh YL; Shin HJ
J Korean Med Sci; 2017 Feb; 32(2):195-203. PubMed ID: 28049229
[TBL] [Abstract][Full Text] [Related]
5. Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children.
Ma Y; Lim DH; Cho H; Lee JW; Sung KW; Yoo KH; Koo HH; Shin HJ; Suh YL
J Korean Med Sci; 2020 Dec; 35(48):e405. PubMed ID: 33316857
[TBL] [Abstract][Full Text] [Related]
6. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
7. Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
Elborai Y; Almutereen M; Maher OM; Hafez H; Lee MA; Lehmann L
J Egypt Natl Canc Inst; 2020 Feb; 32(1):9. PubMed ID: 32372349
[TBL] [Abstract][Full Text] [Related]
8. Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
Sung KW; Lim DH; Son MH; Lee SH; Yoo KH; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ
Neuro Oncol; 2013 Mar; 15(3):352-9. PubMed ID: 23258845
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
Kremens B; Gruhn B; Klingebiel T; Hasan C; Laws HJ; Koscielniak E; Hero B; Selle B; Niemeyer C; Finckenstein FG; Schulz A; Wawer A; Zintl F; Graf N
Bone Marrow Transplant; 2002 Dec; 30(12):893-8. PubMed ID: 12476282
[TBL] [Abstract][Full Text] [Related]
10. The impact on outcomes by using thiotepa in tandem transplant for pediatric high-risk embryonal brain tumors.
Yen HJ; Yu TY; Lee CY; Hung GY; Chiou TJ; Chen HH; Lee YY; Liang ML; Chen YW
J Chin Med Assoc; 2019 Feb; 82(2):148-154. PubMed ID: 30839507
[TBL] [Abstract][Full Text] [Related]
11. High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
Papadopoulos KP; Garvin JH; Fetell M; Vahdat LT; Garrett TJ; Savage DG; Balmaceda C; Bruce J; Sisti M; Isaacson S; De LaPaz R; Hawks R; Bagiella E; Antman KH; Hesdorffer CS
Bone Marrow Transplant; 1998 Oct; 22(7):661-7. PubMed ID: 9818693
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and MarrowTransplant Consortium study.
Gilman AL; Jacobsen C; Bunin N; Levine J; Goldman F; Bendel A; Joyce M; Anderson P; Rozans M; Wall DA; Macdonald TJ; Simon S; Kadota RP
Pediatr Blood Cancer; 2011 Sep; 57(3):506-13. PubMed ID: 21744474
[TBL] [Abstract][Full Text] [Related]
13. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
[TBL] [Abstract][Full Text] [Related]
14. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
[TBL] [Abstract][Full Text] [Related]
15. High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors.
Alsultan A; Alharbi M; Al-Dandan S; Bayoumi Y; Alharbi T; Alsudairy R; Alomari A; Aljamaan K; Musleh O; Alharbi Q; Jarrar M
J Pediatr Hematol Oncol; 2015 Apr; 37(3):204-8. PubMed ID: 25551668
[TBL] [Abstract][Full Text] [Related]
16. Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients.
Choi JY; Kang HJ; An HY; Hong KT; Shin HY
Int J Hematol; 2020 Jun; 111(6):877-887. PubMed ID: 32215821
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma.
Akhtar S; Elhassan TAM; Edesa W; Rauf MS; Zahir MN; Maghfoor I
Ann Hematol; 2016 Jan; 95(1):49-54. PubMed ID: 26467917
[TBL] [Abstract][Full Text] [Related]
20. Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.
Kushner BH; Cheung NK; Kramer K; Dunkel IJ; Calleja E; Boulad F
Bone Marrow Transplant; 2001 Sep; 28(6):551-6. PubMed ID: 11607767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]